Avid Bioservices Announces Grand Opening of New Early-Phase Center of Excellence Facility. Read the Release

Resources

Resources

Quick Links to Fact Sheets

Quick Links to Fact Sheets

Avid Corporate
Capabilities Brochure

Type

Service

DNA to IND Thumbnail
White Paper | Mar 23, 2026
DNA to IND: The Early-Phase Playbook
Inside The Science | Mar 17, 2026
Evolving Protein A Capture in Monoclonal Antibody Manufacturing
White Paper | Feb 18, 2026
Seven Forces Driving Onshoring in Biologics Manufacturing
Blog Post | Jan 15, 2026
Five Questions with Rich McAvoy: Scaling Avid with Discipline
Blog Post | Nov 10, 2025
Five Questions with Dave Stewart: Scaling Avid for What’s Next
White Paper | Oct 27, 2025
Seamless Onshoring from China-based CDMO to Avid Bioservices
Case Study | Oct 17, 2025
Facility-Fit-Driven Process Development for a Monoclonal Antibody (mAb)
Case Study | Oct 16, 2025
Accelerating a Complex Molecule from Cell Line Development to CGMP in 12 Months
Blog Post | Oct 1, 2025
Kenneth Bilenberg on Leading Avid Bioservices and Shaping the Future of Biomanufacturing
Blog Post | Sep 15, 2025
Shaping the future of biologics manufacturing: Q&A with Avid’s new CEO, Kenneth Bilenberg
Fact Sheet
Corporate Capabilities Brochure
Video
Process Development Tour
Tour our expanded state-of-the-art mammalian protein process development facility located in Tustin, CA.
Blog Post | Feb 27, 2025
The Power of “What if”
Video
Mammalian Protein DS Line 2 Tour
Take a virtual tour of our DS Line 2 facility, dedicated to CGMP mammalian protein drug substance manufacturing.
Video
Mammalian Protein DS Line 3 Tour
Tour our state-of-the-art DS Line 3 facility, which is fully equipped to deliver high-quality CGMP mammalian protein products.
Search